A randomised, phase II study of repeated rhenium-188-HEDP combined with docetaxel and prednisone versus docetaxel and prednisone alone in castration-resistant prostate cancer (CRPC) metastatic to bone; the Taxium II trial.
about
A randomised, phase II study of repeated rhenium-188-HEDP combined with docetaxel and prednisone versus docetaxel and prednisone alone in castration-resistant prostate cancer (CRPC) metastatic to bone; the Taxium II trial.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
A randomised, phase II study o ...... to bone; the Taxium II trial.
@ast
A randomised, phase II study o ...... to bone; the Taxium II trial.
@en
type
label
A randomised, phase II study o ...... to bone; the Taxium II trial.
@ast
A randomised, phase II study o ...... to bone; the Taxium II trial.
@en
prefLabel
A randomised, phase II study o ...... to bone; the Taxium II trial.
@ast
A randomised, phase II study o ...... to bone; the Taxium II trial.
@en
P2093
P2860
P1476
A randomised, phase II study o ...... to bone; the Taxium II trial.
@en
P2093
Aart Beeker
Alfons J M van den Eertwegh
Daniela E Oprea-Lager
H Pieter van den Berg
Haiko J Bloemendal
Henk M W Verheul
Joe M O'Sullivan
John M H de Klerk
Joyce M van Dodewaard-de Jong
Maartje Los
P2860
P2888
P304
P356
10.1007/S00259-017-3673-9
P577
2017-04-18T00:00:00Z